[Home]   [Full version]  

Study suggests caution on a new anti-obesity drug in children

May 07 ,Medicine & Health


A new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated. One such drug, rimonabant (trade name Acomplia) has been developed by Sanofi-Aventis and is awaiting approval for use in the U.S., and other pharmaceutical companies are developing similar drugs.

Mark Bear and colleagues published their findings in the May 8, 2008, issue of the journal Neuron, published by Cell Press.

The principal aim of the researchers’ experiments was to gain insight into regulation of the process called “experience-dependent cortical plasticity” in the brain. Such plasticity is the adaptive rewiring of the brain caused by experience that is central to neural development in children and young animals.

For their experimental model, the researchers used plasticity in the visual cortex of the mouse. The visual cortex is the brain region that processes visual signals from the eye, adapting to experience. To study visual cortex plasticity, the researchers used the long-known phenomenon that closing an eye in a young animal causes that eye to lose visual responsiveness—known as a shift in “ocular dominance (OD)—as the visual cortex rapidly adapts due to its plasticity. Specifically, the researchers wanted to understand the regulation of plasticity in two layers, or lamina, of the visual cortex called 2/3 and 4. Also, they knew that activity of the cannabinoid receptor plays a role in plasticity by regulating the signaling connections among neurons.

In their experiments, the researchers closed one eye of an animal and measured the effect on plasticity using recording electrodes implanted in the layers of the visual cortex.

It had been previously believed that plasticity in layer 2/3 was required for plasticity in layer 4. However, the researchers found that when they used a drug called AM 251 to block the cannabinoid receptors in the animals’ brains, plasticity in layer 2/3 was suppressed, but plasticity in layer 4 was unaffected.

“These findings simplify the mechanistic description of plasticity in layer 4, force a revision in the interpretation of previous studies in which laminar differences in OD plasticity mechanisms were unrecognized, and have important implications for the therapeutic use of cannabinoid receptor antagonists in humans,” concluded Bear and colleagues.

Citing the development of obesity drugs that block cannabinoid receptors, the researchers cautioned that “Our finding of a profound disruption of cortical plasticity in juvenile mice treated with AM 251 suggests caution is advised in the use of such compounds in children.”

Source: Cell Press

Related stories:

Study shows compassion meditation changes the brain
Can we train ourselves to be compassionate? A new study suggests the answer is yes. Cultivating compassion and kindness through meditation affects brain regions that can make a person more empathetic to other peoples' mental states, say researchers at the University of Wisconsin-Madison.
'Lazy eye' treatment shows promise in adults
New evidence from a laboratory study and a pilot clinical trial confirms the promise of a simple treatment for amblyopia, or “lazy eye,” according to researchers from the U.S. and China.
Smell experience during critical period alters brain
Unlike the circuitry of the visual system, that of the olfactory system was thought to be hardwired: Once the neurons had formed, no amount of sensory input could change their arrangement. Now researchers at Rockefeller University and their collaborators have upturned this scientific dogma by showing that there is a sensitive period during which the external environment can alter a circuit in the fly brain that detects carbon dioxide, a gas that alerts flies to food and mates.
Sleep loss linked to psychiatric disorders
It has long been assumed that sleep deprivation can play havoc with our emotions. This is notably apparent in soldiers in combat zones, medical residents and even new parents. Now there's a neurological basis for this theory, according to new research from the University of California, Berkeley, and Harvard Medical School.
Adult brain can change, study confirms
It is well established that a child's brain has a remarkable capacity for change, but controversy continues about the extent to which such plasticity exists in the adult human primary sensory cortex. Now, neuroscientists from MIT and Johns Hopkins University have used converging evidence from brain imaging and behavioral studies to show that the adult visual cortex does indeed reorganize-and that the change affects visual perception. The study appears online Sept. 5 in an advance publication of the Journal of Neuroscience.
MIT reports key pathway in synaptic plasticity
Scientists are keenly studying how neurons form synapses--the physical and chemical connections between neurons--and the "pruning" of neural circuits during development, not least because synaptic abnormalities may partially underlie many developmental and neurodegenerative diseases.
How plastic is your brain? UH engineer seeks answers
It may seem easy to change your mind, but if it's your brain we're talking about, maybe it's harder than we think. A University of Houston professor is looking into this with research into something called 'brain plasticity.'
Genetic studies endow mice with new color vision
Although mice, like most mammals, typically view the world with a limited color palette – similar to what some people with red-green color blindness see – scientists have now transformed their vision by introducing a single human gene into a mouse chromosome. The human gene codes for a light sensor that mice do not normally possess, and its insertion allowed the mice to distinguish colors as never before.

News discussion:

Medicine & Health news

[Home]   [Full version]